PT1184366E - Derivados de acido fenilpropionico substituidos como agonistas do receptor alfa activado pelo proliferador do peroxissoma humano (ppar) - Google Patents
Derivados de acido fenilpropionico substituidos como agonistas do receptor alfa activado pelo proliferador do peroxissoma humano (ppar)Info
- Publication number
- PT1184366E PT1184366E PT00935582T PT00935582T PT1184366E PT 1184366 E PT1184366 E PT 1184366E PT 00935582 T PT00935582 T PT 00935582T PT 00935582 T PT00935582 T PT 00935582T PT 1184366 E PT1184366 E PT 1184366E
- Authority
- PT
- Portugal
- Prior art keywords
- acid derivatives
- ppar
- human
- peroxystom
- proliferator
- Prior art date
Links
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical group OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 102000023984 PPAR alpha Human genes 0.000 abstract 1
- 108010028924 PPAR alpha Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 210000002824 peroxisome Anatomy 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16223599 | 1999-06-09 | ||
| JP2000157600A JP4618845B2 (ja) | 1999-06-09 | 2000-05-29 | ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1184366E true PT1184366E (pt) | 2005-06-30 |
Family
ID=26488107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00935582T PT1184366E (pt) | 1999-06-09 | 2000-06-08 | Derivados de acido fenilpropionico substituidos como agonistas do receptor alfa activado pelo proliferador do peroxissoma humano (ppar) |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6506797B1 (pt) |
| EP (1) | EP1184366B1 (pt) |
| JP (1) | JP4618845B2 (pt) |
| KR (1) | KR100704142B1 (pt) |
| CN (1) | CN1157368C (pt) |
| AT (1) | ATE288887T1 (pt) |
| AU (1) | AU773445B2 (pt) |
| BR (1) | BR0011734A (pt) |
| CA (1) | CA2376094C (pt) |
| DE (1) | DE60018064T2 (pt) |
| DK (1) | DK1184366T3 (pt) |
| ES (1) | ES2235886T3 (pt) |
| HU (1) | HUP0201654A3 (pt) |
| NO (1) | NO327957B1 (pt) |
| NZ (1) | NZ515705A (pt) |
| PT (1) | PT1184366E (pt) |
| WO (1) | WO2000075103A1 (pt) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU778282B2 (en) * | 1999-09-17 | 2004-11-25 | Kyorin Pharmaceutical Co. Ltd. | O-anisamide derivatives |
| TWI262185B (en) * | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| US6768008B2 (en) * | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US7049342B2 (en) * | 2000-05-29 | 2006-05-23 | Kyorin Pharmaceutical Co., Ltd. | Substituted phenylpropionic acid derivatives |
| SI1285908T1 (sl) * | 2000-05-29 | 2008-12-31 | Kyorin Seiyaku Kk | Substituirani fenilpropionski kislinski derivati |
| JPWO2002044130A1 (ja) * | 2000-11-29 | 2004-04-02 | 杏林製薬株式会社 | 置換カルボン酸誘導体 |
| WO2002044129A1 (fr) * | 2000-11-29 | 2002-06-06 | Kyorin Pharmaceutical Co., Ltd. | Dérivés d'acide carboxylique substitués |
| AU2002222552A1 (en) * | 2000-11-29 | 2002-06-11 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
| AU2002222551A1 (en) * | 2000-11-29 | 2002-06-11 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
| US7176204B2 (en) | 2000-12-05 | 2007-02-13 | Kyorin Pahrmaceutical Co., Ltd. | Substituted carboxylic acid derivatives |
| JPWO2002046146A1 (ja) * | 2000-12-05 | 2004-04-08 | 杏林製薬株式会社 | 置換カルボン酸誘導体 |
| EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
| US7507767B2 (en) | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| US7253178B2 (en) * | 2001-03-28 | 2007-08-07 | Eisai Co., Ltd. | Carboxylic acids |
| WO2002081428A1 (fr) * | 2001-03-30 | 2002-10-17 | Eisai Co., Ltd. | Compose de benzene et sel de ce compose |
| WO2002080899A1 (fr) * | 2001-03-30 | 2002-10-17 | Eisai Co., Ltd. | Agent de traitement de maladie digestive |
| TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| JPWO2002098840A1 (ja) | 2001-06-04 | 2004-09-16 | エーザイ株式会社 | カルボン酸誘導体及びその塩もしくはそのエステルからなる医薬 |
| US7371777B2 (en) | 2001-08-17 | 2008-05-13 | Eisai Co., Ltd. | Cyclic compound and PPAR agonist |
| EP2168576A3 (en) * | 2001-09-14 | 2010-05-26 | Shionogi & Co., Ltd. | Tricyclic compounds for treating dyslipidemia and arteriosclerotic diseases |
| WO2003050077A1 (fr) * | 2001-12-11 | 2003-06-19 | Kyorin Pharmaceutical Co., Ltd. | Cristaux stables de derive d'acide phenylpropionique substitue et procede de production associe |
| GB0314079D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0229931D0 (en) | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| JP4446387B2 (ja) * | 2002-05-27 | 2010-04-07 | 杏林製薬株式会社 | （２ｓ）−２−エチルフェニルプロピオン酸誘導体 |
| SE0201936D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
| US7355069B2 (en) * | 2002-06-20 | 2008-04-08 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
| US7351858B2 (en) | 2002-06-20 | 2008-04-01 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| US20070154543A1 (en) * | 2003-04-16 | 2007-07-05 | Kyorin Pharmaceutical Co., Ltd | Solid preparation for oral use |
| JPWO2005009942A1 (ja) * | 2003-07-28 | 2006-09-07 | 杏林製薬株式会社 | 光学活性置換フェニルプロピオン酸誘導体 |
| US7902367B2 (en) * | 2004-08-11 | 2011-03-08 | Kyorin Pharmaceutical Co., Ltd. | Cyclic amino benzoic acid derivative |
| PL371841A1 (pl) | 2004-12-20 | 2006-06-26 | ADAMED Sp.z o.o. | Nowe związki pochodne kwasu 3-fenylopropionowego |
| PL372332A1 (pl) | 2005-01-19 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| PL372356A1 (pl) * | 2005-01-20 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| WO2006090756A1 (ja) * | 2005-02-25 | 2006-08-31 | Kyorin Pharmaceutical Co., Ltd. | 脂質代謝異常、肥満および糖尿病の新規な予防または治療剤およびそのための使用 |
| JPWO2006093354A1 (ja) * | 2005-03-04 | 2008-08-07 | 杏林製薬株式会社 | （ｓ）−２−［３−（ｎ−｛［４−（４−フルオロフェノキシ）フェニル］メチル｝カルバモイル）−４−メトキシフェニルメチル］ブタン酸の製造中間体 |
| JPWO2006101108A1 (ja) * | 2005-03-23 | 2008-09-04 | 杏林製薬株式会社 | 新規環状アミノフェニルアルカン酸誘導体 |
| JP2007001912A (ja) * | 2005-06-22 | 2007-01-11 | Univ Of Tokyo | 置換フェニルプロピオン酸誘導体 |
| FR2898892A1 (fr) * | 2006-03-24 | 2007-09-28 | Genfit Sa | Derives de n-(phenethyl)benzamide substitues,preparation et utilisations |
| CN101054372B (zh) * | 2006-04-11 | 2010-10-13 | 中国科学院上海药物研究所 | 嘧啶取代苯丙酸衍生化合物、其制法和在治疗多囊肾疾病中的用途 |
| CN101466687B (zh) | 2006-04-18 | 2012-04-11 | 日本化学医药株式会社 | 过氧化物酶体增殖剂激活受体δ的激活剂 |
| AU2013202514B2 (en) * | 2006-04-18 | 2015-09-17 | Nippon Chemiphar Co., Ltd. | Activating agent for peroxisome proliferator activated receptor delta |
| WO2008004341A1 (fr) * | 2006-07-03 | 2008-01-10 | The University Of Tokyo | DÉRIVÉS DE L'ACIDE PHÉNYLPROPIONIQUE SUBSTITUÉS EN α |
| KR20090066289A (ko) | 2006-09-08 | 2009-06-23 | 로드아일랜드하스피틀 | 알코올 유발성 뇌 질환의 치료, 예방 및 역행 |
| AU2008221673B2 (en) * | 2007-03-08 | 2013-03-28 | Albireo Ab | 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease |
| MX2010011252A (es) | 2008-04-15 | 2010-11-30 | Nippon Chemiphar Co | Activador para el receptor activado por el proliferador de peroxisoma. |
| BRPI0912716A2 (pt) * | 2008-05-13 | 2015-10-13 | Genmedica Therapeutics Sl | composto. |
| AU2009323367B2 (en) | 2008-12-01 | 2013-05-23 | Mitsubishi Tanabe Pharma Corporation | Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
| BRPI1013878A2 (pt) | 2009-03-16 | 2016-04-05 | Genmedica Therapeutics Sl | método para tratar distúrbios metabólicos, e, composto |
| US8466197B2 (en) | 2010-12-14 | 2013-06-18 | Genmedica Therapeutics Sl | Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders |
| CN105324362B (zh) | 2013-03-15 | 2017-05-24 | 百时美施贵宝公司 | Ido抑制剂 |
| JPWO2015046317A1 (ja) * | 2013-09-30 | 2017-03-09 | 国立大学法人 岡山大学 | 新規アセチレンアミド誘導体 |
| EP3317249A1 (en) * | 2015-07-02 | 2018-05-09 | The Medical College of Wisconsin, Inc. | Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble epoxide hydrolase and peroxisome proliferator-activated receptors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK148576A (da) * | 1975-04-18 | 1976-10-19 | Boehringer Mannheim Gmbh | Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
-
2000
- 2000-05-29 JP JP2000157600A patent/JP4618845B2/ja not_active Expired - Fee Related
- 2000-06-08 HU HU0201654A patent/HUP0201654A3/hu unknown
- 2000-06-08 CA CA002376094A patent/CA2376094C/en not_active Expired - Fee Related
- 2000-06-08 NZ NZ515705A patent/NZ515705A/xx not_active IP Right Cessation
- 2000-06-08 KR KR1020017015777A patent/KR100704142B1/ko not_active IP Right Cessation
- 2000-06-08 WO PCT/JP2000/003707 patent/WO2000075103A1/ja active IP Right Grant
- 2000-06-08 EP EP00935582A patent/EP1184366B1/en not_active Expired - Lifetime
- 2000-06-08 US US10/009,175 patent/US6506797B1/en not_active Expired - Fee Related
- 2000-06-08 DE DE60018064T patent/DE60018064T2/de not_active Expired - Lifetime
- 2000-06-08 AU AU51067/00A patent/AU773445B2/en not_active Ceased
- 2000-06-08 DK DK00935582T patent/DK1184366T3/da active
- 2000-06-08 BR BR0011734-0A patent/BR0011734A/pt not_active IP Right Cessation
- 2000-06-08 AT AT00935582T patent/ATE288887T1/de active
- 2000-06-08 ES ES00935582T patent/ES2235886T3/es not_active Expired - Lifetime
- 2000-06-08 PT PT00935582T patent/PT1184366E/pt unknown
- 2000-06-08 CN CNB008086869A patent/CN1157368C/zh not_active Expired - Fee Related
-
2001
- 2001-12-07 NO NO20016001A patent/NO327957B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6506797B1 (en) | 2003-01-14 |
| DE60018064D1 (de) | 2005-03-17 |
| ATE288887T1 (de) | 2005-02-15 |
| JP2001055367A (ja) | 2001-02-27 |
| BR0011734A (pt) | 2002-03-05 |
| KR20020008221A (ko) | 2002-01-29 |
| CA2376094C (en) | 2007-06-05 |
| NO20016001L (no) | 2002-02-11 |
| CN1157368C (zh) | 2004-07-14 |
| CA2376094A1 (en) | 2000-12-04 |
| DK1184366T3 (da) | 2005-05-23 |
| NO20016001D0 (no) | 2001-12-07 |
| JP4618845B2 (ja) | 2011-01-26 |
| HUP0201654A2 (en) | 2002-09-28 |
| WO2000075103A1 (fr) | 2000-12-14 |
| EP1184366A1 (en) | 2002-03-06 |
| NO327957B1 (no) | 2009-10-26 |
| ES2235886T3 (es) | 2005-07-16 |
| CN1354742A (zh) | 2002-06-19 |
| HUP0201654A3 (en) | 2004-03-01 |
| EP1184366A4 (en) | 2002-10-31 |
| AU5106700A (en) | 2000-12-28 |
| DE60018064T2 (de) | 2006-01-12 |
| KR100704142B1 (ko) | 2007-04-09 |
| NZ515705A (en) | 2003-02-28 |
| EP1184366B1 (en) | 2005-02-09 |
| AU773445B2 (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1184366E (pt) | Derivados de acido fenilpropionico substituidos como agonistas do receptor alfa activado pelo proliferador do peroxissoma humano (ppar) | |
| CY1108586T1 (el) | Υποκαταστημενα παραγωγα φαινυλοπροπιονικου οξεος | |
| AR022469A1 (es) | Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias | |
| IL162330A0 (en) | Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) | |
| IL175310A0 (en) | Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists | |
| EP1348698A4 (en) | SUBSTITUTED CARBOXYLIC ACID DERIVATIVES | |
| JO2493B1 (en) | New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses | |
| ES2051834T3 (es) | El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad. | |
| ECSP055986A (es) | Derivados de ácido 3-(2-fenil-oxazol-4-ilmetoxi)ciclohexilmetoxiacético y compuestos relacionados utilizados como moduladores de ppar para tratar diabetes de tipo 2 y arterioesclerosis | |
| ES2053856T3 (es) | Derivados del acido 4-quinoleino carboxilico utiles para el tratamiento de enfermedades de la piel y del muco-epitelio. | |
| DK0501378T3 (da) | NMDA-antagonister | |
| MX26167A (es) | Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino. | |
| PT1179342E (pt) | Composicoes medicinais de libertacao imediata para utilizacao oral | |
| EP1207156A4 (en) | SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DION DERIVATIVES | |
| EP1207157A4 (en) | SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DION DERIVATIVES | |
| CO5690587A2 (es) | Derivados de acido bensoilureidopiridil-piperidin-y pirrolidin carboxilico sustituido, metodo para su produccion y su uso | |
| HUT52478A (en) | Process for producing glycerin derivatives and pharmaceutical compositions comprising same | |
| CA2487450A1 (en) | (2s)-2-ethylphenylpropanoic acid derivatives | |
| EP1207158A4 (en) | SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DION DERIVATIVES | |
| TH8124A (th) | อนุพันธ์ของ2-ออกซ์อินโดลที่ถูกแทนที่ที่ตำแหน่ง 3 |